Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Jun;95(6):2465–2473. doi: 10.1172/JCI117947

Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients.

T Aoyama 1, M Souri 1, S Ushikubo 1, T Kamijo 1, S Yamaguchi 1, R I Kelley 1, W J Rhead 1, K Uetake 1, K Tanaka 1, T Hashimoto 1
PMCID: PMC295925  PMID: 7769092

Abstract

Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase (VLCAD) was purified from human liver. The molecular masses of the native enzyme and the subunit were estimated to be 154 and 70 kD, respectively. The enzyme was found to catalyze the major part of mitochondrial palmitoylcoenzyme A dehydrogenation in liver, heart, skeletal muscle, and skin fibroblasts (89-97, 86-99, 96-99, and 78-87%, respectively). Skin fibroblasts from 26 patients suspected of having a disorder of mitochondrial beta-oxidation were analyzed for VLCAD protein using immunoblotting, and 7 of them contained undetectable or trace levels of the enzyme. The seven deficient fibroblast lines were characterized by measuring acyl-coenzyme A dehydrogenation activities, overall palmitic acid oxidation, and VLCAD protein synthesis using pulse-chase, further confirming the diagnosis of VLCAD deficiency. These results suggested the heterogenous nature of the mutations causing the deficiency in the seven patients. Clinically, all patients with VLCAD deficiency exhibited cardiac disease. At least four of them presented with hypertrophic cardiomyopathy. This frequency (> 57%) was much higher than that observed in patients with other disorders of mitochondrial long-chain fatty acid oxidation that may be accompanied by cardiac disease in infants.

Full text

PDF
2469

Images in this article

2467Image
on p.2467
2469Image
on p.2469
2469Image
on p.2469
2470Image
on p.2470
2470Image
on p.2470

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison F., Bennett M. J., Variend S., Engel P. C. Acylcoenzyme A dehydrogenase deficiency in heart tissue from infants who died unexpectedly with fatty change in the liver. Br Med J (Clin Res Ed) 1988 Jan 2;296(6614):11–12. doi: 10.1136/bmj.296.6614.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Amendt B. A., Greene C., Sweetman L., Cloherty J., Shih V., Moon A., Teel L., Rhead W. J. Short-chain acyl-coenzyme A dehydrogenase deficiency. Clinical and biochemical studies in two patients. J Clin Invest. 1987 May;79(5):1303–1309. doi: 10.1172/JCI112953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aoyama T., Souri M., Kamijo T., Ushikubo S., Hashimoto T. Peroxisomal acyl-coenzyme A oxidase is a rate-limiting enzyme in a very-long-chain fatty acid beta-oxidation system. Biochem Biophys Res Commun. 1994 Jun 30;201(3):1541–1547. doi: 10.1006/bbrc.1994.1879. [DOI] [PubMed] [Google Scholar]
  4. Aoyama T., Uchida Y., Kelley R. I., Marble M., Hofman K., Tonsgard J. H., Rhead W. J., Hashimoto T. A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase. Biochem Biophys Res Commun. 1993 Mar 31;191(3):1369–1372. doi: 10.1006/bbrc.1993.1368. [DOI] [PubMed] [Google Scholar]
  5. Aoyama T., Ueno I., Kamijo T., Hashimoto T. Rat very-long-chain acyl-CoA dehydrogenase, a novel mitochondrial acyl-CoA dehydrogenase gene product, is a rate-limiting enzyme in long-chain fatty acid beta-oxidation system. cDNA and deduced amino acid sequence and distinct specificities of the cDNA-expressed protein. J Biol Chem. 1994 Jul 22;269(29):19088–19094. [PubMed] [Google Scholar]
  6. Bertrand C., Largillière C., Zabot M. T., Mathieu M., Vianey-Saban C. Very long chain acyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid oxidation in fibroblasts. Biochim Biophys Acta. 1993 Jan 22;1180(3):327–329. doi: 10.1016/0925-4439(93)90058-9. [DOI] [PubMed] [Google Scholar]
  7. Coates P. M., Hale D. E., Finocchiaro G., Tanaka K., Winter S. C. Genetic deficiency of short-chain acyl-coenzyme A dehydrogenase in cultured fibroblasts from a patient with muscle carnitine deficiency and severe skeletal muscle weakness. J Clin Invest. 1988 Jan;81(1):171–175. doi: 10.1172/JCI113290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Coates P. M., Tanaka K. Molecular basis of mitochondrial fatty acid oxidation defects. J Lipid Res. 1992 Aug;33(8):1099–1110. [PubMed] [Google Scholar]
  9. Corr P. B., Creer M. H., Yamada K. A., Saffitz J. E., Sobel B. E. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest. 1989 Mar;83(3):927–936. doi: 10.1172/JCI113978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Demaugre F., Bonnefont J. P., Colonna M., Cepanec C., Leroux J. P., Saudubray J. M. Infantile form of carnitine palmitoyltransferase II deficiency with hepatomuscular symptoms and sudden death. Physiopathological approach to carnitine palmitoyltransferase II deficiencies. J Clin Invest. 1991 Mar;87(3):859–864. doi: 10.1172/JCI115090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Furuta S., Miyazawa S., Hashimoto T. Purification and properties of rat liver acyl-CoA dehydrogenases and electron transfer flavoprotein. J Biochem. 1981 Dec;90(6):1739–1750. doi: 10.1093/oxfordjournals.jbchem.a133651. [DOI] [PubMed] [Google Scholar]
  12. Hale D. E., Batshaw M. L., Coates P. M., Frerman F. E., Goodman S. I., Singh I., Stanley C. A. Long-chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia. Pediatr Res. 1985 Jul;19(7):666–671. doi: 10.1203/00006450-198507000-00006. [DOI] [PubMed] [Google Scholar]
  13. Hale D. E., Bennett M. J. Fatty acid oxidation disorders: a new class of metabolic diseases. J Pediatr. 1992 Jul;121(1):1–11. doi: 10.1016/s0022-3476(05)82532-6. [DOI] [PubMed] [Google Scholar]
  14. Hale D. E., Stanley C. A., Coates P. M. Genetic defects of acyl-CoA dehydrogenases: studies using an electron transfer flavoprotein reduction assay. Prog Clin Biol Res. 1990;321:333–348. [PubMed] [Google Scholar]
  15. Hale D. E., Stanley C. A., Coates P. M. The long-chain acyl-CoA dehydrogenase deficiency. Prog Clin Biol Res. 1990;321:303–311. [PubMed] [Google Scholar]
  16. Howat A. J., Bennett M. J., Variend S., Shaw L., Engel P. C. Defects of metabolism of fatty acids in the sudden infant death syndrome. Br Med J (Clin Res Ed) 1985 Jun 15;290(6484):1771–1773. doi: 10.1136/bmj.290.6484.1771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ikeda Y., Dabrowski C., Tanaka K. Separation and properties of five distinct acyl-CoA dehydrogenases from rat liver mitochondria. Identification of a new 2-methyl branched chain acyl-CoA dehydrogenase. J Biol Chem. 1983 Jan 25;258(2):1066–1076. [PubMed] [Google Scholar]
  18. Ikeda Y., Okamura-Ikeda K., Tanaka K. Purification and characterization of short-chain, medium-chain, and long-chain acyl-CoA dehydrogenases from rat liver mitochondria. Isolation of the holo- and apoenzymes and conversion of the apoenzyme to the holoenzyme. J Biol Chem. 1985 Jan 25;260(2):1311–1325. [PubMed] [Google Scholar]
  19. Indo Y., Coates P. M., Hale D. E., Tanaka K. Immunochemical characterization of variant long-chain acyl-CoA dehydrogenase in cultured fibroblasts from nine patients with long-chain acyl-CoA dehydrogenase deficiency. Pediatr Res. 1991 Sep;30(3):211–215. doi: 10.1203/00006450-199109000-00001. [DOI] [PubMed] [Google Scholar]
  20. Izai K., Uchida Y., Orii T., Yamamoto S., Hashimoto T. Novel fatty acid beta-oxidation enzymes in rat liver mitochondria. I. Purification and properties of very-long-chain acyl-coenzyme A dehydrogenase. J Biol Chem. 1992 Jan 15;267(2):1027–1033. [PubMed] [Google Scholar]
  21. Kamijo T., Wanders R. J., Saudubray J. M., Aoyama T., Komiyama A., Hashimoto T. Mitochondrial trifunctional protein deficiency. Catalytic heterogeneity of the mutant enzyme in two patients. J Clin Invest. 1994 Apr;93(4):1740–1747. doi: 10.1172/JCI117158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kelly D. P., Whelan A. J., Ogden M. L., Alpers R., Zhang Z. F., Bellus G., Gregersen N., Dorland L., Strauss A. W. Molecular characterization of inherited medium-chain acyl-CoA dehydrogenase deficiency. Proc Natl Acad Sci U S A. 1990 Dec;87(23):9236–9240. doi: 10.1073/pnas.87.23.9236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kølvraa S., Gregersen N., Christensen E., Hobolth N. In vitro fibroblast studies in a patient with C6-C10-dicarboxylic aciduria: evidence for a defect in general acyl-CoA dehydrogenase. Clin Chim Acta. 1982 Nov 24;126(1):53–67. doi: 10.1016/0009-8981(82)90361-8. [DOI] [PubMed] [Google Scholar]
  24. Lehman T. C., Hale D. E., Bhala A., Thorpe C. An acyl-coenzyme A dehydrogenase assay utilizing the ferricenium ion. Anal Biochem. 1990 May 1;186(2):280–284. doi: 10.1016/0003-2697(90)90080-s. [DOI] [PubMed] [Google Scholar]
  25. MASSEY V. The microestimation of succinate and the extinction coefficient of cytochrome c. Biochim Biophys Acta. 1959 Jul;34:255–256. doi: 10.1016/0006-3002(59)90259-8. [DOI] [PubMed] [Google Scholar]
  26. Naito E., Indo Y., Tanaka K. Identification of two variant short chain acyl-coenzyme A dehydrogenase alleles, each containing a different point mutation in a patient with short chain acyl-coenzyme A dehydrogenase deficiency. J Clin Invest. 1990 May;85(5):1575–1582. doi: 10.1172/JCI114607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Naito E., Indo Y., Tanaka K. Short chain acyl-coenzyme A dehydrogenase (SCAD) deficiency. Immunochemical demonstration of molecular heterogeneity due to variant SCAD with differing stability. J Clin Invest. 1989 Nov;84(5):1671–1674. doi: 10.1172/JCI114346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rhead W. J., Amendt B. A., Fritchman K. S., Felts S. J. Dicarboxylic aciduria: deficient [1-14C]octanoate oxidation and medium-chain acyl-CoA dehydrogenase in fibroblasts. Science. 1983 Jul 1;221(4605):73–75. doi: 10.1126/science.6857268. [DOI] [PubMed] [Google Scholar]
  29. Rhead W. J. Inborn errors of fatty acid oxidation in man. Clin Biochem. 1991 Aug;24(4):319–329. doi: 10.1016/0009-9120(91)80006-o. [DOI] [PubMed] [Google Scholar]
  30. Saudubray J. M., Mitchell G., Bonnefont J. P., Schwartz G., Nuttin C., Munnich A., Brivet M., Vassault A., Demaugre F., Rabier D. Approach to the patient with a fatty acid oxidation disorder. Prog Clin Biol Res. 1992;375:271–288. [PubMed] [Google Scholar]
  31. Stanley C. A., DeLeeuw S., Coates P. M., Vianey-Liaud C., Divry P., Bonnefont J. P., Saudubray J. M., Haymond M., Trefz F. K., Breningstall G. N. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann Neurol. 1991 Nov;30(5):709–716. doi: 10.1002/ana.410300512. [DOI] [PubMed] [Google Scholar]
  32. Stanley C. A., Hale D. E., Coates P. M., Hall C. L., Corkey B. E., Yang W., Kelley R. I., Gonzales E. L., Williamson J. R., Baker L. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels. Pediatr Res. 1983 Nov;17(11):877–884. doi: 10.1203/00006450-198311000-00008. [DOI] [PubMed] [Google Scholar]
  33. Tonsgard J. H., Stephens J. K., Rhead W. J., Penn D., Horwitz A. L., Kirschner B. S., Whitington P. F., Berger S., Tripp M. E. Defect in fatty acid oxidation: laboratory and pathologic findings in a patient. Pediatr Neurol. 1991 Mar-Apr;7(2):125–130. doi: 10.1016/0887-8994(91)90009-a. [DOI] [PubMed] [Google Scholar]
  34. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Treem W. R., Stanley C. A., Finegold D. N., Hale D. E., Coates P. M. Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts. N Engl J Med. 1988 Nov 17;319(20):1331–1336. doi: 10.1056/NEJM198811173192006. [DOI] [PubMed] [Google Scholar]
  36. Tripp M. E., Katcher M. L., Peters H. A., Gilbert E. F., Arya S., Hodach R. J., Shug A. L. Systemic carnitine deficiency presenting as familial endocardial fibroelastosis: a treatable cardiomyopathy. N Engl J Med. 1981 Aug 13;305(7):385–390. doi: 10.1056/NEJM198108133050707. [DOI] [PubMed] [Google Scholar]
  37. Turnbull D. M., Bartlett K., Stevens D. L., Alberti K. G., Gibson G. J., Johnson M. A., McCulloch A. J., Sherratt H. S. Short-chain acyl-CoA dehydrogenase deficiency associated with a lipid-storage myopathy and secondary carnitine deficiency. N Engl J Med. 1984 Nov 8;311(19):1232–1236. doi: 10.1056/NEJM198411083111906. [DOI] [PubMed] [Google Scholar]
  38. Yamaguchi S., Indo Y., Coates P. M., Hashimoto T., Tanaka K. Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency. Pediatr Res. 1993 Jul;34(1):111–113. doi: 10.1203/00006450-199307000-00025. [DOI] [PubMed] [Google Scholar]
  39. Yokota I., Coates P. M., Hale D. E., Rinaldo P., Tanaka K. Molecular survey of a prevalent mutation, 985A-to-G transition, and identification of five infrequent mutations in the medium-chain Acyl-CoA dehydrogenase (MCAD) gene in 55 patients with MCAD deficiency. Am J Hum Genet. 1991 Dec;49(6):1280–1291. [PMC free article] [PubMed] [Google Scholar]
  40. Yokota I., Indo Y., Coates P. M., Tanaka K. Molecular basis of medium chain acyl-coenzyme A dehydrogenase deficiency. An A to G transition at position 985 that causes a lysine-304 to glutamate substitution in the mature protein is the single prevalent mutation. J Clin Invest. 1990 Sep;86(3):1000–1003. doi: 10.1172/JCI114761. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES